MYGN
Myriad Genetics
$5.45
−$0.16 (−2.85%)Jul 27, 2026
Key metrics
The numbers that frame MYGN today
- Market cap
- $514.74M
- P/E (TTM)
- -1.3
- EV / FCF
- -25.9
- Gross margin
- 70%
- EV / Sales
- 0.7
- ROIC
- -94.5%
- Div yield
- 0%
- Debt / equity
- 0.6
- 52wk Low
- $3.53
- 52wk High
- $8.59
Growth
Revenue and earnings trend for MYGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MYGN
Is Myriad Genetics a good buy?
Hold. Myriad Genetics has strong quality and mixed momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Myriad Genetics is selling at a high price.
What is the market capitalization of MYGN?
Myriad Genetics's market capitalization is $514.74M.
What is the P/E ratio for MYGN stock?
Myriad Genetics's current P/E ratio is -1.3.
What is the 52-week high for MYGN stock?
The 52-week high for Myriad Genetics is $8.59. The current close of $5.45 is 36.6% below that high.
What is the 52-week low for MYGN stock?
The 52-week low for Myriad Genetics is $3.53. The current close of $5.45 is 54.4% above that low.
Does MYGN stock pay dividends?
Myriad Genetics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MYGN?
Myriad Genetics's Debt / Equity ratio is 0.63.